Long term outcome and response to therapy of primary biliary cirrhosis - Autoimmune hepatitis overlap syndrome

Journal of Hepatology

Volumn 44, Issue 2, 2006, Pages 400-406

  Chazouillères, Olivier ^a,b   Wendum, Dominique ^a   Serfaty, Lawrence ^a   Rosmorduc, Olivier ^a   Poupon, Raoul ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b HÔPITAL SAINT ANTOINE   (France)

Author keywords

Autoimmune hepatitis; Autoimmunity; Corticosteroids; Overlap syndrome; Primary biliary cirrhosis; Ursodeoxycholic acid

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT; URSODEOXYCHOLIC ACID;

ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; AUTOIMMUNITY; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER BIOPSY; LIVER FIBROSIS; LONG TERM CARE; MALE; MONOTHERAPY; PRIMARY BILIARY CIRRHOSIS; PRIMARY HEALTH CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; AGED; BIOPSY; CHOLAGOGUES AND CHOLERETICS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SYNDROME; TIME FACTORS; TREATMENT OUTCOME; URSODEOXYCHOLIC ACID;

EID: 30344478833     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.10.017     Document Type: Article

References (29)

1. G. Kloppel, G. Seifert, H. Lindner, R. Dammermann, H.J. Sack, and P.A. Berg Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis Virchows Arch A Pathol Anat Histopathol 373 1977 143 160
2. T. Okuno, Y. Seto, T. Okanoue, and T. Takino Chronic active hepatitis with histological features of primary biliary cirrhosis Dig Dis Sci 32 1987 775 779
3. J.G. Carrougher, R.T. Shaffer, L.I. Canales, and Z.D. Goodman A 33-year-old woman with an autoimmune syndrome Semin Liver Dis 11 1991 256 262
4. Z. Ben-Ari, A.P. Dhillon, and S. Sherlock Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis Hepatology 18 1993 10 15
5. L.A. Colombato, F. Alvarez, J. Cote, and P.M. Huet Autoimmune cholangiopathy: the result of consecutive primary biliary cirrhosis and autoimmune hepatitis ? Gastroenterology 107 1994 1839 1843
6. P.A. Davis, P. Leung, M. Manns, M. Kaplan, S.J. Munoz, and F.A. Gorin M4 and M9 antibodies in the overlap syndrome of primary biliary cirrhosis and chronic active hepatitis: epitopes or epiphenomena? Hepatology 16 1992 1128 1136
7. J.C. Duclos-Vallée, A. Hadengue, N. Ganne-Carrie, E. Robin, C. Degott, and S. Erlinger Primary biliary cirrhosis - autoimmune hepatitis overlap syndrome. Corticoresistance and effective treament by cyclosporine A Dig Dis Sci 40 1995 1069 1073
8. O. Chazouillères, D. Wendum, L. Serfaty, S. Montembault, O. Rosmorduc, and R. Poupon Primary biliary cirrhosis - autoimmune hepatitis overlap syndrome: clinical features and response to therapy Hepatology 28 1998 296 301
9. A.W. Lohse, K.H. Meyer Zum Büschenfelde, B. Franz, S. Kanzler, and G. Gerken Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals Hepatology 29 1999 1078 1084
10. J. Woodward, and J. Neuberger Autoimmune overlap syndromes Hepatology 33 2001 994 1002
11. Z. Ben-Ari, and A.J. Czaja Autoimmune hepatitis and its variant syndromes Gut 49 2001 589 594
12. D.J. van Leeuwen, G. Sood, D. Ferrante, A.J. Lazenby, and M.J. Sellers A 38-year-old African-American woman with an unusually rapid progression of 'primary biliary cirrhosis': a missed opportunity Semin Liver Dis 22 2002 395 405
13. S. Joshi, K. Cauch-Dudek, I.R. Wanless, K.D. Lindor, R. Jorgensen, and K. Batts Primary biliary cirrhosis with additional features of autoimmune hepatitis: response to therapy with ursodeoxycholic acid Hepatology 35 2002 409 413
14. F. Alvarez, P.A. Berg, F.B. Bianchi, L. Bianchi, A.K. Burroughs, and E.L. Cancado International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis J Hepatol 31 1999 929 938
15. A.J. Czaja, and D.K. Freese Diagnosis and treatment of autoimmune hepatitis Hepatology 36 2002 479 497
16. H. Rautiainen, P. Karkkainen, A-L. Karvonen, H. Nurmi, P. Pikkarainen, and H. Nuutinen Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: a three-year randomized trial Hepatology 41 2005 747 752
17. The METAVIR Cooperative Group Inter- and intra-observer variation in the assessment of liver biopsy of chronic hepatitis C Hepatology 20 1994 15 20
18. P. Bedossa, T. Poynard, and for the METAVIR cooperative study group An algorithm for the grading of activity in chronic hepatitis C Hepatology 24 1996 289 293
19. R. Poupon Autoimmune overlapping syndromes Clin Liver Dis 7 2003 865 878
20. O. Chazouillères Diagnosis of primary sclerosing cholangitis - autoimmune hepatitis overlap syndrome: to score or not to score ? J Hepatol 33 2000 661 663
21. C. Corpechot, F. Carrat, A.-M. Bonnand, R.E. Poupon, and R. Poupon The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis Hepatology 32 2000 1196 1199
22. S. Joshi, and E.J. Heathcote Ursodeoxycholic acid and primary biliary cirrhosis with features of autoimmune hepatitis Hepatology 36 2002 1026 1027 (reply)
23. K. Nakamura, M. Yoneda, S. Yokohama, K. Tamori, Y. Sato, and K. Aso Efficacy of ursodeoxycholic acid in Japanese patients with type-1 autoimmune hepatitis J Gastroenterol Hepatol 13 1998 457 459
24. R. Poupon Trials in primary biliary cirrhosis: need for the right drugs at the right time Hepatology 39 2004 900 902
25. C. Degott, E.S. Zafrani, P. Callard, B. Balkau, R.E. Poupon, and R. Poupon Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression Hepatology 29 1999 1007 1012
26. C. Corpechot, F. Carrat, R. Poupon, and R.E. Poupon Primary biliary cirrhosis: incidence and predictive factors of cirrhosis in ursodiol-treated patients Gastroenterology 122 2002 652 658
27. M. Leuschner, S. Güldütuna, T. You, K. Hübner, S. Bhatti, and U. Leuschner Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis J Hepatol 25 1996 49 57
28. M. Leuschner, K.-P. Maier, J. Schlichting, S. Strahl, G. Herrmann, and H.H. Dahm Oral budesonide and ursodeoxycholic acid for treatment of primary biliary cirrhosis: results of a prospective double-blind trial Gastroenterology 117 1999 918 925
29. E.J. Heathcote Management of primary biliary cirrhosis Hepatology 31 2000 1005 1013